Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	808.21	780.57	631.45	566.77	463.93	276.87
Revenue Growth	14.31%	23.61%	11.41%	22.17%	67.56%	-10.69%
Gross Profit Gross Profit Growth	722.93	693.64	547.92	471.93	345.74	217.8
Operating Income Operating Income Growth	171.65	193.09	199.63	175.46	38.11	22.21
Net Income Net Income Growth	47.92	62.87	69.19	48.16	-25	71.52
Earnings Per Share EPS Growth	1.41	1.73	1.86	1.29	-0.74	1.86
EPS Growth	32.73%	-6.56%	43.56%	-	-	144.25%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	129.47	386.68	162.76	310.55	173.69	186.43
Total Debt Total Debt Growth	1,218	936.43	979.91	674.28	709.18	258.75
Net Cash (Debt) Net Cash Growth	-1,088	-549.75	-817.15	-363.74	-535.49	-72.32
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-30.07	-13.85	-20.21	-8.70	-15.83	-1.76

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	329.92	329.32	204.98	274.75	124.23	103.56
Capital Expenditures CapEx Growth	-1.64	-1.74	-1.65	-0.46	-1.62	-1.94
Free Cash Flow Free Cash Flow Growth	328.28	327.58	203.33	274.29	122.61	101.61
Free Cash Flow Growth	62.67%	61.11%	-25.87%	123.71%	20.66%	14.95%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	89.45%	88.86%	86.77%	83.27%	74.52%	78.66%
Operating Margin	21.24%	24.74%	31.61%	30.96%	8.21%	8.02%
Pretax Margin	9.61%	11.87%	15.61%	13.36%	-6.22%	-1.22%
Profit Margin	5.93%	8.05%	10.96%	8.50%	-5.39%	25.83%
FCF Margin	40.62%	41.97%	32.20%	48.39%	26.43%	36.70%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	15.54	23.28	13.35	20.84	-	9.09
Forward PE	3.15	6.11	4.54	5.57	4.01	4.57
P/FCF Ratio	2.17	4.47	4.54	3.66	6.35	6.40
PS Ratio	0.88	1.88	1.46	1.77	1.68	2.35

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error